Grant RadarWorldwide funding

Browse grants Log in Get started

Health Open for ApplicationsRFA-CA-27-001

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

National Institutes of Health opportunity RFA-CA-27-001

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthRFA-CA-27-001Grants.gov

Related Grants

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Amount not stated

23 Dec 2027(412d)

Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)

Amount not stated

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Amount not stated

16 Nov 2027(375d)

Mechanisms Underlying Olfactory Dysfunction in Aging and Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias

Amount not stated

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Application Deadline

10 November 2026

4 days remaining

Opens: 3 Jun 2026

Programme Details

Programme Code

RFA-CA-27-001